The development of minimally invasive glaucoma surgeries (MIGSs) was intended to
provide safe and modestly efficacious modalities for early intervention of mild-to-moderate …

For moderate-to-severe glaucoma, trabeculectomy remains the “gold standard” intraocular
pressure (IOP)-lowering treatment; nonetheless, this method requires extensive post …

Purpose: The purpose of this study was to assess the safety and efficacy of the PSM for the
treatment of open angle glaucoma with 0.2 mg/mL mitomycin C, either alone or in …

Introduction To analyze the effects of PRESERFLO on corneal endothelial cell density
(ECD). Methods Forty-six eyes that underwent PRESERFLO implantation were followed up …

Background: The purpose of this study is to compare the morphology of six-month follow-up
blebs created by a subconjunctival glaucoma surgical device (XEN45) to those created by a …

Purpose: To measure the in vitro flow properties of the PRESERFLO implant for comparison
with the theoretical resistance to flow. Methods: The PRESERFLO was designed to control …

Purpose: The purpose of this study was to evaluate the effectiveness and safety of an open
bleb revision with mitomycin-C (MMC) for bleb fibrosis after PreserFlo MicroShunt …

Purpose To investigate the possible risk factors for treatment failure in patients who had
undergone Preserflo Microshunt (PMS) implantation, using anterior-segment optical …

The formation of filtration blebs is the main drainage mechanism for reducing intraocular
pressure after traditional incisional glaucoma surgery such as trabeculectomy and non …

Purpose The aim this study is to determine anterior chamber parameters variations induced
by PreserFlo MicroShunt implantation, in the early post-operative days. Methods This is a …